The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on March 06, 2026 for Aayush Agrawal, Trustee ....
AJANTPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Ajanta Pharma promoter Aayush Agrawal, trustee of Aayush Agrawal Trust, has disclosed pledging activities on the company's shares. He created a fresh pledge on 7,87,933 shares and released pledges on 8,32,178 shares. The creation was to raise an additional loan, while the releases were for loan repayment and reducing margin requirements. Multiple transactions between Feb 24 and Mar 5, 2026 involved lenders such as Aditya Birla Capital, Deutsche Bank, Standard Chartered, HSBC, Jio Finance, and Bajaj Finance. Net effect is a reduction in pledged shares by about 44,245 shares, signaling deleveraging by the promoter.
Net release of pledged shares indicates the promoter is reducing leverage and strengthening financial flexibility, which is generally viewed positively by investors. The disclosure does not indicate any invocation of pledge or distress sale.